Skip to main content

Advertisement

Log in

Surgical treatment of 61 consecutive patients with maxillary stage 3 medication–related osteonecrosis of the jaws using a pedicled buccal fat pad

  • Original Article
  • Published:
Oral and Maxillofacial Surgery Aims and scope Submit manuscript

Abstract

Purpose

Buccal fat pad (BFP) is used for the closure of large oroantral defects caused by surgical removal of the necrotic bone in patients with medication-related osteonecrosis of the jaw (MRONJ). This study aimed to evaluate the use of BFP for the closure of maxillary sinus defects in stage 3 MRONJ patients.

Methods

This study recruited 61patients with large oroantral defects caused by MRONJ, including 49 patients with cancer and 12 patients with osteoporosis. Lesions were evaluated clinically and radiographically.

Results

Among the 61 patients, 51 (83.6%) healed uneventfully, and 5 patients (8.2%) had local dehiscence and exposed bone; these 56 patients (91.8%) all healed after first or second operation. The Eastern Cooperative Oncology Group Performance Status was associated with being non-cured and might be an indicator for the healing process. All patients experienced a significant increase in body weight postoperatively.

Conclusions

This study suggest that block resection with removal of the necrotic bone combined with radical sinusotomy and closure of the defect with BFP is a reliable method to cure MRONJ lesions with a high success rate, and successful operation and prosthetic rehabilitation may improve body weight and the quality of life.

The study was approved by the appropriate ethical approval for the Copenhagen ONJ Cohort (protocol no. H-6–2013-010) November 20, 2013.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Availability of data and material

Not applicable.

Code availability

Not applicable.

References

  1. Marx RE (2003) Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 61(9):1115–1117. https://doi.org/10.1016/s0278-2391(03)00720-1

    Article  PubMed  Google Scholar 

  2. Ruggiero SL, Mehrotra B, Rosenberg TJ, Engroff SL (2004) Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. J Oral Maxillofac Surg 62(5):527–534. https://doi.org/10.1016/j.joms.2004.02.004

    Article  PubMed  Google Scholar 

  3. Ruggiero S, Gralow J, Marx RE, Hoff AO, Schubert MM, Huryn JM, Toth B, Damato K, Valero V (2006) Practical guidelines for the prevention, diagnosis, and treatment of osteonecrosis of the jaw in patients with cancer. J Oncol Pract 2(1):7–14. https://doi.org/10.1200/jop.2006.2.1.7

    Article  PubMed  PubMed Central  Google Scholar 

  4. Ruggiero SL, Dodson TB, Assael LA, Landesberg R, Marx RE, Mehrotra B (2009) American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaw — 2009 update. Aust Endod J 35(3):119–130. https://doi.org/10.1111/j.1747-4477.2009.00213.x

    Article  PubMed  Google Scholar 

  5. Ruggiero SL, Dodson TB, Fantasia J, Goodday R, Aghaloo T, Mehrotra B, O’Ryan F (2014) American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw—2014 update. J Oral Maxillofac Surg 72(10):1938–1956. https://doi.org/10.1016/j.joms.2014.04.031

    Article  PubMed  Google Scholar 

  6. Schiodt M, Reibel J, Oturai P, Kofod T (2014) Comparison of nonexposed and exposed bisphosphonate-induced osteonecrosis of the jaws: a retrospective analysis from the Copenhagen cohort and a proposal for an updated classification system. Oral Surg Oral Med Oral Pathol Oral Radiol 117(2):204–213. https://doi.org/10.1016/j.oooo.2013.10.010

    Article  PubMed  Google Scholar 

  7. Otto S, Pautke C, Van den Wyngaert T, Niepel D, Schiødt M (2018) Medication-related osteonecrosis of the jaw: prevention, diagnosis and management in patients with cancer and bone metastases. Cancer Treat Rev 69:177–187. https://doi.org/10.1016/j.ctrv.2018.06.007

    Article  PubMed  Google Scholar 

  8. Saad F, Brown JE, Van Poznak C, Ibrahim T, Stemmer SM, Stopeck AT, Diel IJ, Takahashi S, Shore N, Henry DH, Barrios CH, Facon T, Senecal F, Fizazi K, Zhou L, Daniels A, Carriere P, Dansey R (2012) Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases. Ann Oncol 23(5):1341–1347. https://doi.org/10.1093/annonc/mdr435

    Article  CAS  PubMed  Google Scholar 

  9. Stuzin JM, Wagstrom L, Kawamoto HK, Baker TJ, Wolfe SA (1990) The anatomy and clinical applications of the buccal fat pad. Plast Reconstr Surg 85(1):29–37. https://doi.org/10.1097/00006534-199001000-00006

    Article  CAS  PubMed  Google Scholar 

  10. Nabil S, Ramli R (2012) The use of buccal fat pad flap in the treatment of osteoradionecrosis. Int J Oral Maxillofac Surg 41(11):1422–1426. https://doi.org/10.1016/j.ijom.2012.04.001

    Article  CAS  PubMed  Google Scholar 

  11. Toshihiro Y, Nariai Y, Takamura Y, Yoshimura H, Tobita T, Yoshino A, Tatsumi H, Tsunematsu K, Ohba S, Kondo S, Yanai C, Ishibashi H, Sekine J (2013) Applicability of buccal fat pad grafting for oral reconstruction. Int J Oral Maxillofac Surg 42(5):604–610. https://doi.org/10.1016/j.ijom.2012.07.009

    Article  CAS  PubMed  Google Scholar 

  12. Castellani A, Bocchialini G, Negrini S, Zanetti U, Rossi A (2015) The pedicled buccal fat pad in oral reconstruction. Minerva Stomatol 64(6):283–293

    CAS  PubMed  Google Scholar 

  13. Hewson I, Syme D, Bruscino-Raiola F (2012) Radical surgical treatment of bisphosphonate related osteonecrosis of the jaw. Aust Dent J 57(2):227–230. https://doi.org/10.1111/j.1834-7819.2012.01675.x

    Article  CAS  PubMed  Google Scholar 

  14. Mucke T, Haarmann S, Wolff KD, Holzle F (2009) Bisphosphonate related osteonecrosis of the jaws treated by surgical resection and immediate osseous microvascular reconstruction. J Craniomaxillofac Surg 37(5):291–297. https://doi.org/10.1016/j.jcms.2008.12.004

    Article  PubMed  Google Scholar 

  15. Duarte LFM, Alonso K, Basso EC, Dib LL (2015) Surgical treatment of bisphosphonate-related osteonecrosis of the jaws with the use of buccal fat pad: case report. Braz Dent J 26(3):317–320. https://doi.org/10.1590/0103-6440201301918

    Article  PubMed  Google Scholar 

  16. Denes SA, Tieghi R, Elia G (2016) The buccal fat pad for closure of oroantral communication. J Craniofac Surg 27(3):e327-330. https://doi.org/10.1097/scs.0000000000002579

    Article  PubMed  Google Scholar 

  17. Şahin O, Odabaşı O, Ekmekcioğlu C (2019) Ultrasonic piezoelectric bone surgery combined with L-PRF and pedicled buccal fat pad flap in denosumab-related osteonecrosis of the jaw. J Craniofac Surg. https://doi.org/10.1097/SCS.0000000000005472

    Article  PubMed  Google Scholar 

  18. Gallego L, Junquera L, Pelaz A, Hernando J, Megias J (2012) The use of pedicled buccal fat pad combined with sequestrectomy in bisphosphonate-related osteonecrosis of the maxilla. Medicina Oral Patología Oral y Cirugia Bucal: e236-e241. https://doi.org/10.4317/medoral.17422

  19. Berrone M, Florindi FU, Carbone V, Aldiano C, Pentenero M (2015) Stage 3 medication-related osteonecrosis of the posterior maxilla: surgical treatment using a pedicled buccal fat pad flap: case reports. J Oral Maxillofac Surg 73(11):2082–2086. https://doi.org/10.1016/j.joms.2015.06.165

    Article  PubMed  Google Scholar 

  20. Rotaru H, Kim MK, Kim SG, Park YW (2015) Pedicled buccal fat pad flap as a reliable surgical strategy for the treatment of medication-related osteonecrosis of the jaw. J Oral Maxillofac Surg 73(3):437–442. https://doi.org/10.1016/j.joms.2014.09.023

    Article  PubMed  Google Scholar 

  21. Hakobyan K, Poghosyan Y, Kasyan A (2018) The use of buccal fat pad in surgical treatment of ‘Krokodil’ drug-related osteonecrosis of maxilla. J Craniomaxillofac Surg 46(5):831–836

    Article  PubMed  Google Scholar 

  22. Jose A, Rawat A, Nagori SA, Arya S, Shukla D (2021) Outcomes of sequestrectomy and buccal fat pad reconstruction in the management of medication-related osteonecrosis of the jaws. Oral Maxillofac Surg 1:3. https://doi.org/10.1007/s10006-021-00973-9

    Article  Google Scholar 

  23. Aljohani S, Troeltzsch M, Hafner S, Kaeppler G, Mast G, Otto S (2018) Surgical treatment of medication-related osteonecrosis of the upper jaw: case series. Oral Dis. https://doi.org/10.1111/odi.12992

    Article  PubMed  Google Scholar 

  24. Melville JC, Tursun R, Shum JW, Young S, Hanna IA, Marx RE (2016) A technique for the treatment of oral-antral fistulas resulting from medication-related osteonecrosis of the maxilla: the combined buccal fat pad flap and radical sinusotomy. Oral Surg Oral Med Oral Pathol Oral Radiol 122(3):287–291. https://doi.org/10.1016/j.oooo.2016.03.015

    Article  PubMed  Google Scholar 

  25. Ristow O, Rückschloß T, Bodem J, Berger M, Bodem E, Kargus S, Engel M, Hoffmann J, Freudlsperger C (2018) Double-layer closure techniques after bone surgery of medication-related osteonecrosis of the jaw — a single center cohort study. J Craniomaxillofac Surg 46(5):815–824. https://doi.org/10.1016/j.jcms.2018.03.005

    Article  PubMed  Google Scholar 

  26. Laimer J, Höller A, Pichler U, Engel R, Neururer SB, Egger A, Griesmacher A, Bruckmoser E (2021) Nutritional status in patients with medication-related osteonecrosis of the jaw (MRONJ). Nutrients 13 (5). doi:https://doi.org/10.3390/nu13051585

  27. Parfitt AM (1983) Dietary risk factors for age-related bone loss and fractures. Lancet 2(8360):1181–1185. https://doi.org/10.1016/s0140-6736(83)91226-6

    Article  CAS  PubMed  Google Scholar 

  28. Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5(6):649–655

    Article  CAS  PubMed  Google Scholar 

  29. Hakobyan K, Poghosyan Y (2019) “Krokodil” drug — related osteonecrosis of midface: a case series. J Craniomaxillofac Surg 47(12):1918–1921. https://doi.org/10.1016/j.jcms.2019.11.002

    Article  PubMed  Google Scholar 

  30. Chiandussi S, Biasotto M, Dore F, Cavalli F, Cova MA, Di Lenarda R (2006) Clinical and diagnostic imaging of bisphosphonate-associated osteonecrosis of the jaws. Dentomaxillofac Radiol 35(4):236–243. https://doi.org/10.1259/dmfr/27458726

    Article  CAS  PubMed  Google Scholar 

  31. Wasserzug O, Kaffe I, Lazarovici TS, Weissman T, Yahalom R, Fliss DM, Yarom N (2017) Involvement of the maxillary sinus in bisphosphonate-related osteonecrosis of the jaw: radiologic aspects. Am J Rhinol Allergy 31(1):36–39. https://doi.org/10.2500/ajra.2017.31.4395

    Article  PubMed  Google Scholar 

  32. Schiodt M, Otto S, Fedele S, Bedogni A, Nicolatou-Galitis O, Guggenberger R, Herlofson BB, Ristow O, Kofod T (2019) Workshop of European task force on medication-related osteonecrosis of the jaw—current challenges. Oral Dis 25(7):1815–1821. https://doi.org/10.1111/odi.13160

    Article  PubMed  Google Scholar 

  33. Nisi M, La Ferla F, Karapetsa D, Gennai S, Miccoli M, Baggiani A, Graziani F, Gabriele M (2015) Risk factors influencing BRONJ staging in patients receiving intravenous bisphosphonates: a multivariate analysis. Int J Oral Maxillofac Surg 44(5):586–591. https://doi.org/10.1016/j.ijom.2015.01.014

    Article  CAS  PubMed  Google Scholar 

  34. Kim HY, Lee SJ, Kim SM, Myoung H, Hwang SJ, Choi JY, Lee JH, Choung PH, Kim MJ, Seo BM (2017) Extensive surgical procedures result in better treatment outcomes for bisphosphonate-related osteonecrosis of the jaw in patients with osteoporosis. J Oral Maxillofac Surg 75(7):1404–1413. https://doi.org/10.1016/j.joms.2016.12.014

    Article  PubMed  Google Scholar 

  35. Mast G, Otto S, Mücke T, Schreyer C, Bissinger O, Kolk A, Wolff KD, Ehrenfeld M, Stürzenbaum SR, Pautke C (2012) Incidence of maxillary sinusitis and oro-antral fistulae in bisphosphonate-related osteonecrosis of the jaw. J Craniomaxillofac Surg 40(7):568–571. https://doi.org/10.1016/j.jcms.2011.10.012

    Article  PubMed  Google Scholar 

  36. Murphy J, Mannion CJ (2020) Medication-related osteonecrosis of the jaws and quality of life: review and structured analysis. Br J Oral Maxillofac Surg. https://doi.org/10.1016/j.bjoms.2020.03.010

    Article  PubMed  Google Scholar 

  37. Sato T, Kusumoto J, Takeda D, Kishimoto M, Kashin M, Furudoi S, Akashi M (2020) Which symptoms negatively affect the oral health-related quality of life in patients with osteonecrosis of the jaw? Oral Surg Oral Med Oral Pathol Oral Radiol 130(2):175–180. https://doi.org/10.1016/j.oooo.2020.03.051

    Article  PubMed  Google Scholar 

  38. Vescovi P, Manfredi M, Merigo E, Meleti M (2008) Early surgical approach preferable to medical therapy for bisphosphonate-related osteonecrosis of the jaws. J Oral Maxillofac Surg 66(4):831–832. https://doi.org/10.1016/j.joms.2007.11.025

    Article  PubMed  Google Scholar 

  39. Otto S, Ristow O, Pache C, Troeltzsch M, Fliefel R, Ehrenfeld M, Pautke C (2016) Fluorescence-guided surgery for the treatment of medication-related osteonecrosis of the jaw: a prospective cohort study. J Craniomaxillofac Surg. https://doi.org/10.1016/j.jcms.2016.05.018

    Article  PubMed  Google Scholar 

  40. Ristow O, Otto S, Geiss C, Kehl V, Berger M, Troeltzsch M, Koerdt S, Hohlweg-Majert B, Freudlsperger C, Pautke C (2017) Comparison of auto-fluorescence and tetracycline fluorescence for guided bone surgery of medication-related osteonecrosis of the jaw: a randomized controlled feasibility study. Int J Oral Maxillofac Surg 46(2):157–166. https://doi.org/10.1016/j.ijom.2016.10.008

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

Sanne Werner Moeller Andersen: conceptualization, data curation, formal analysis, investigation, methodology, project administration, supervision, validation, visualization, writing original draft, writing review, and editing.

Ditte Gertz Mogensen: conceptualization, data curation, formal analysis, investigation, methodology, project administration, software, validation, writing original draft, writing review, and editing.

Morten Schiodt: conceptualization, data curation, formal analysis, investigation, methodology, project administration, resources, supervision, validation, visualization.

Thomas Kofod: conceptualization, investigation, resources, supervision, validation, writing review, and editing.

Corresponding author

Correspondence to Sanne Werner Moeller Andersen.

Ethics declarations

Ethics approval

Ethic committee H-6–2013-010 November 20, 2013.

Consent to participate

All patients signed an informed consent.

Consent for publication

Not applicable.

Conflict of interest

Morten Schiodt has been a consultant for Amgen. Other authors have no conflicts of interest to declare.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Morten Schioedt passed away before the submission

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Andersen, S.W.M., Mogensen, D.G., Schioedt, M. et al. Surgical treatment of 61 consecutive patients with maxillary stage 3 medication–related osteonecrosis of the jaws using a pedicled buccal fat pad. Oral Maxillofac Surg 27, 251–261 (2023). https://doi.org/10.1007/s10006-022-01061-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10006-022-01061-2

Keywords

Navigation